Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-86594
Ö. Topaloğlu, Sakin Tekin, Seda Nur Topaloğlu, T. Bayraktaroğlu
Subacute thyroiditis (SAT) has been recently associated with severe acute respiratory syndrome-coronavirus-2 infection or vaccines against it. We report a case of a 41-year-old male patient who developed persistent SAT after the coronavirus disease-2019 (COVID-19) vaccination. He presented with sore throat and neck pain after the first dose of the COVID-19 vaccine (CoronaVac®). There was no history of a recent viral infection. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were elevated, thyroidstimulating hormone (TSH) and free thyroxine (fT4) were normal, COVID-19 polymerase chain reaction test was negative, and sonography showed thyroiditis in the right lobe. The symptoms resolved after treatment with methylprednisolone. However, 2 weeks after the second dose of the vaccine, the patient suffered from neck pain and hoarseness. TSH and fT4 were normal, but anti-thyroid peroxidase (anti- TPO), anti-thyroglobulin (anti-Tg), ESR, and CRP were elevated. Sonography revealed thyroiditis in the left lobe. The patient was treated with ibuprofen. On follow-up, hypothyroidism was diagnosed, and levothyroxine started. Hence, the clinicians should suspect the possibility of SAT in the vaccinated subjects. (English) [ FROM AUTHOR] Subakut tiroidit (SAT), son zamanlarda şiddetli akut solunum sendromu-koronavirüs-2 enfeksiyonu veya buna karşı geliştirilen aşılarla ilişkilendirilmektedir. Koronavirüs hastalığı- 2019 [coronavirus disease-2019 (COVID-19)] aşılaması sonrasında persistan SAT gelişen 41 yaşında erkek hastamızı sunuyoruz. COVID-19 aşısının (CoronaVac®) ilk dozundan sonra boğaz ağrısı ve boyun ağrısı ile başvurdu. Yakın zamanda viral enfeksiyon öyküsü yoktu. Eritrosit sedimentasyon hızı (ESH) ve C-reaktif protein (CRP) yüksekti, tiroidstimüle edici hormon (TSH) ve serbest tiroksin (sT4) normaldi, COVID-19 polimeraz zincir reaksiyonu testi negatifti ve sonografide sağ lobta tiroidit mevcuttu. Metilprednizolon tedavisi ile semptomlar geriledi. Ancak aşının 2. dozundan 2 hafta sonra hasta boyun ağrısı ve ses kısıklığından yakındı. TSH ve sT4 normaldi, anti-tiroid peroksidaz, anti-tiroglobülin, ESH ve CRP yükseldi. Sonografide sol lobta tiroidit izlendi. Hasta ibuprofen ile tedavi edildi. Takipte, hipotiroidizm tanısıyla levotiroksin başlandı. Dolayısıyla klinisyenler aşılanmış kişilerde SAT olasılığını akılda tutmalıdır. (Turkish) [ FROM AUTHOR] Copyright of Turkish Journal of Endocrinology & Metabolism is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
亚急性甲状腺炎(SAT)最近与严重急性呼吸综合征-冠状病毒-2感染或针对它的疫苗有关。我们报告一例41岁男性患者在冠状病毒病-2019 (COVID-19)疫苗接种后出现持续性SAT。他在第一剂COVID-19疫苗(CoronaVac®)后出现喉咙痛和颈部疼痛。近期无病毒感染史。红细胞沉降率(ESR)、c反应蛋白(CRP)升高，促甲状腺激素(TSH)、游离甲状腺素(fT4)正常，COVID-19聚合酶链反应试验阴性，超声示右叶甲状腺炎。甲强的松龙治疗后症状消失。然而，在第二次接种疫苗2周后，患者出现颈部疼痛和声音嘶哑。TSH、fT4正常，但抗甲状腺过氧化物酶(anti- TPO)、抗甲状腺球蛋白(anti- tg)、ESR、CRP升高。超声显示左叶甲状腺炎。病人用布洛芬治疗。在随访中，诊断为甲状腺功能减退，并开始使用左旋甲状腺素。因此，临床医生应该怀疑接种疫苗的受试者中存在SAT的可能性。(中文)[来源]Subakut tiroidit (SAT)， son zamanlarda iddetli akut solunum sendromu- koronavir -2 enfeksiyonu veya buna kar ilygeli tirilen aşılarla ili kilendirilmektedir。koronavir s hastalığı- 2019[冠状病毒病-2019 (COVID-19)] aşılaması sonrasında persistan SAT geli 41 yaşında erkek hastamızı sunuyoruz。COVID-19 aşısının (CoronaVac®)ilk dozundan sonra boğaz ağrısı ve boyun ağrısı ile ba vurdu。Yakın zamanda病毒enfeksiyon öyküsü yoktu。利特沙沉积症hızı (ESH) ve C-reaktif蛋白(CRP) y ksekti, tiroidstim促生激素(TSH) ve serbest tiroksin (sT4)正常，COVID-19聚合锌(zir) reaksiyonu检测阴性，超声心动图salaklota tiroidit mecuttu。甲替尼唑酮可引起症状性痴呆。安卡aşının12月2日，hafta sonra hasta boyun ağrısı ve ses kısıklığından yakındı。TSH ve sT4正常，抗类固醇peroksidaz，抗tiroglobine, ESH ve CRP y kseldi。超声心动图是一种有效的治疗方法。哈斯塔布洛芬是我的父亲。Takipte, hipotiroidizm tanısıyla左旋roksin ba。Dolayısıyla klinisyenler aşılanmış ki ilerde SAT olasılığını akılda tutmalıdır。(土耳其)[来自作者]土耳其内分泌与代谢杂志版权所有是Galenos Yayinevi Tic的财产。有限公司未经版权所有者的明确书面许可，STI及其内容不得复制或通过电子邮件发送到多个网站或发布到listserv。但是，用户可以打印、下载或通过电子邮件发送文章供个人使用。这可以删节。对副本的准确性不作任何保证。用户应参阅原始出版版本的材料的完整。(版权适用于所有人。)
{"title":"Persistent Subacute Thyroiditis Post SARS-CoV-2 Vaccine in a Male Patient with Positive Thyroid Autoantibodies","authors":"Ö. Topaloğlu, Sakin Tekin, Seda Nur Topaloğlu, T. Bayraktaroğlu","doi":"10.25179/tjem.2021-86594","DOIUrl":"https://doi.org/10.25179/tjem.2021-86594","url":null,"abstract":"Subacute thyroiditis (SAT) has been recently associated with severe acute respiratory syndrome-coronavirus-2 infection or vaccines against it. We report a case of a 41-year-old male patient who developed persistent SAT after the coronavirus disease-2019 (COVID-19) vaccination. He presented with sore throat and neck pain after the first dose of the COVID-19 vaccine (CoronaVac®). There was no history of a recent viral infection. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were elevated, thyroidstimulating hormone (TSH) and free thyroxine (fT4) were normal, COVID-19 polymerase chain reaction test was negative, and sonography showed thyroiditis in the right lobe. The symptoms resolved after treatment with methylprednisolone. However, 2 weeks after the second dose of the vaccine, the patient suffered from neck pain and hoarseness. TSH and fT4 were normal, but anti-thyroid peroxidase (anti- TPO), anti-thyroglobulin (anti-Tg), ESR, and CRP were elevated. Sonography revealed thyroiditis in the left lobe. The patient was treated with ibuprofen. On follow-up, hypothyroidism was diagnosed, and levothyroxine started. Hence, the clinicians should suspect the possibility of SAT in the vaccinated subjects. (English) [ FROM AUTHOR] Subakut tiroidit (SAT), son zamanlarda şiddetli akut solunum sendromu-koronavirüs-2 enfeksiyonu veya buna karşı geliştirilen aşılarla ilişkilendirilmektedir. Koronavirüs hastalığı- 2019 [coronavirus disease-2019 (COVID-19)] aşılaması sonrasında persistan SAT gelişen 41 yaşında erkek hastamızı sunuyoruz. COVID-19 aşısının (CoronaVac®) ilk dozundan sonra boğaz ağrısı ve boyun ağrısı ile başvurdu. Yakın zamanda viral enfeksiyon öyküsü yoktu. Eritrosit sedimentasyon hızı (ESH) ve C-reaktif protein (CRP) yüksekti, tiroidstimüle edici hormon (TSH) ve serbest tiroksin (sT4) normaldi, COVID-19 polimeraz zincir reaksiyonu testi negatifti ve sonografide sağ lobta tiroidit mevcuttu. Metilprednizolon tedavisi ile semptomlar geriledi. Ancak aşının 2. dozundan 2 hafta sonra hasta boyun ağrısı ve ses kısıklığından yakındı. TSH ve sT4 normaldi, anti-tiroid peroksidaz, anti-tiroglobülin, ESH ve CRP yükseldi. Sonografide sol lobta tiroidit izlendi. Hasta ibuprofen ile tedavi edildi. Takipte, hipotiroidizm tanısıyla levotiroksin başlandı. Dolayısıyla klinisyenler aşılanmış kişilerde SAT olasılığını akılda tutmalıdır. (Turkish) [ FROM AUTHOR] Copyright of Turkish Journal of Endocrinology & Metabolism is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"87 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131416737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-86517
Ayesha Fauzi, Adeline Chia YOKE YIN, T. Quan
Introduction Diabetes mellitus (DM) is a prevalent metabolic disease affecting the global population and has been dubbed as an epidemic by the World Health Organization (WHO). Recent data has estimated that approximately 629 million people will be affected by 2049, making diabetes a notable healthcare economy burden (1). Epidemiologically, DM and lesser forms, such as glucose intolerance, impaired glucose tolerance, and impaired fasting glucose, are prevalent in every population in the world, and without prevention and early control programs, cases are increasing at an alarming rate. DM can be classified into Type 1, Type 2, gestational DM The prevalence of diabetes mellitus is increasing at an alarming rate worldwide. With no cure available, effective disease management is the best way to control disease progression. Studies have shown that diabetes technology helps to improve health outcomes and the quality of life of the patients. Diabetes technology can be defined as any solution encompassing hardware, devices, and software used in the disease management of patients. This review serves as an introduction to diabetes mellitus by discussing the different categories of well-established diabetes technology, related ongoing research, and its challenges. This review is divided into 3 main categories, insulin administration, glucose monitoring, and hybrid devices that combine the 2 categories into one. Digital health application is also discussed as it is becoming a notable tool in the disease management of diabetes. Widespread use of these devices in disease management has been increasing in recent years. However, there are still barriers that prevent the utilization of the full potential of these devices.
{"title":"Current Diabetes Technology and its Challenges","authors":"Ayesha Fauzi, Adeline Chia YOKE YIN, T. Quan","doi":"10.25179/tjem.2021-86517","DOIUrl":"https://doi.org/10.25179/tjem.2021-86517","url":null,"abstract":"Introduction Diabetes mellitus (DM) is a prevalent metabolic disease affecting the global population and has been dubbed as an epidemic by the World Health Organization (WHO). Recent data has estimated that approximately 629 million people will be affected by 2049, making diabetes a notable healthcare economy burden (1). Epidemiologically, DM and lesser forms, such as glucose intolerance, impaired glucose tolerance, and impaired fasting glucose, are prevalent in every population in the world, and without prevention and early control programs, cases are increasing at an alarming rate. DM can be classified into Type 1, Type 2, gestational DM The prevalence of diabetes mellitus is increasing at an alarming rate worldwide. With no cure available, effective disease management is the best way to control disease progression. Studies have shown that diabetes technology helps to improve health outcomes and the quality of life of the patients. Diabetes technology can be defined as any solution encompassing hardware, devices, and software used in the disease management of patients. This review serves as an introduction to diabetes mellitus by discussing the different categories of well-established diabetes technology, related ongoing research, and its challenges. This review is divided into 3 main categories, insulin administration, glucose monitoring, and hybrid devices that combine the 2 categories into one. Digital health application is also discussed as it is becoming a notable tool in the disease management of diabetes. Widespread use of these devices in disease management has been increasing in recent years. However, there are still barriers that prevent the utilization of the full potential of these devices.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128785117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2019-66224
M. Çalapkulu, O. O. Gul, S. Cander, C. Ersoy, E. Erturk, B. Hakyemez
{"title":"An Unusual Case of Ectopic Prolactinoma in the Clivus","authors":"M. Çalapkulu, O. O. Gul, S. Cander, C. Ersoy, E. Erturk, B. Hakyemez","doi":"10.25179/tjem.2019-66224","DOIUrl":"https://doi.org/10.25179/tjem.2019-66224","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114875255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2018-63123
A. Or Koca, M. Altay
{"title":"Transient Elevation of CA 19-9 Due to Cessation of Levothyroxine in a Patient with Hashimoto’s Thyroiditis","authors":"A. Or Koca, M. Altay","doi":"10.25179/tjem.2018-63123","DOIUrl":"https://doi.org/10.25179/tjem.2018-63123","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125857351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/TJEM.2018-63015
Mehrunnisha Ahmad, F. Kashoo, M. Alqahtani, W. Sami, M. Rizvi, Amira Y. Bushra
{"title":"Relation Between Night Eating Syndrome and Academic Grades Among University Students","authors":"Mehrunnisha Ahmad, F. Kashoo, M. Alqahtani, W. Sami, M. Rizvi, Amira Y. Bushra","doi":"10.25179/TJEM.2018-63015","DOIUrl":"https://doi.org/10.25179/TJEM.2018-63015","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"438 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122144492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2018-64300
R. Mekova, M. Boyanov
®Copyright 2019 by Turkish Journal of Endocrinology and Metabolism Association Turkish Journal of Endocrinology and Metabolism published by Türkiye Klinikleri Frequency Profile and Clinical Correlations of TSH Receptor Antibodies in Euthyroid and Hypothyroid Patients Having Autoimmune Thyroiditis Otoimmün Tiroiditi Bulunan, Ötiroid ve Hipotiroid Hastalarda TSH Reseptör Antikorlarının Sıklık Profilleri ve Klinik Korelasyonları
®Copyright 2019 by Turkish Journal of Endocrinology and Metabolism Association 土耳其内分泌学和新陈代谢杂志》由 Türkiye Klinikleri 出版。
{"title":"Frequency Profile and Clinical Correlations of TSH Receptor Antibodies in Euthyroid and Hypothyroid Patients Having Autoimmune Thyroiditis","authors":"R. Mekova, M. Boyanov","doi":"10.25179/tjem.2018-64300","DOIUrl":"https://doi.org/10.25179/tjem.2018-64300","url":null,"abstract":"®Copyright 2019 by Turkish Journal of Endocrinology and Metabolism Association Turkish Journal of Endocrinology and Metabolism published by Türkiye Klinikleri Frequency Profile and Clinical Correlations of TSH Receptor Antibodies in Euthyroid and Hypothyroid Patients Having Autoimmune Thyroiditis Otoimmün Tiroiditi Bulunan, Ötiroid ve Hipotiroid Hastalarda TSH Reseptör Antikorlarının Sıklık Profilleri ve Klinik Korelasyonları","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125275548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/TJEM.2018-63768
Mehtap Evran Olgun, Gamze Akkuş, Mustafa Gök, Ç. Çağlıyan, I. Ünal, M. Sert, T. Tetiker
{"title":"Effect of Vitamin D Treatment on Glycemic Control, Diastolic Functions, and Carotid Intima-Media Thickness in Patients with Type 2 Diabetes Mellitus","authors":"Mehtap Evran Olgun, Gamze Akkuş, Mustafa Gök, Ç. Çağlıyan, I. Ünal, M. Sert, T. Tetiker","doi":"10.25179/TJEM.2018-63768","DOIUrl":"https://doi.org/10.25179/TJEM.2018-63768","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"60 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123118280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-81148
F. Bayram, R. Sarı, F. K. Kucukler, M. Araz, R. Çolak, O. Başpınar, Y. Kucukardali, M. Çalan, C. Yılmaz, Onur Utebay, T. Tetiker
Treatment Patterns and Associated Clinical Outcomes in Type 2 Diabetes Patients Initiating Second-Line Glucose-Lowering Therapy: Interim Analysis of Baseline Data from Turkey Arm of the Global DISCOVER Study İkinci-Sıra Glukoz Düşürücü Tedaviye Başlanan Tip 2 Diyabet Hastalarında Tedavi Uygulamaları ve İlişkili Klinik Sonuçlar: Global DISCOVER Çalışması Türkiye Kolu Başlangıç Verilerinin Ara Analizi
{"title":"Treatment Patterns and Associated Clinical Outcomes in Type 2 Diabetes Patients Initiating Second-Line Glucose-Lowering Therapy: Interim Analysis of Baseline Data from Turkey Arm of the Global DISCOVER Study","authors":"F. Bayram, R. Sarı, F. K. Kucukler, M. Araz, R. Çolak, O. Başpınar, Y. Kucukardali, M. Çalan, C. Yılmaz, Onur Utebay, T. Tetiker","doi":"10.25179/tjem.2021-81148","DOIUrl":"https://doi.org/10.25179/tjem.2021-81148","url":null,"abstract":"Treatment Patterns and Associated Clinical Outcomes in Type 2 Diabetes Patients Initiating Second-Line Glucose-Lowering Therapy: Interim Analysis of Baseline Data from Turkey Arm of the Global DISCOVER Study İkinci-Sıra Glukoz Düşürücü Tedaviye Başlanan Tip 2 Diyabet Hastalarında Tedavi Uygulamaları ve İlişkili Klinik Sonuçlar: Global DISCOVER Çalışması Türkiye Kolu Başlangıç Verilerinin Ara Analizi","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"475 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131995710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2019-66617
Ayşen Caniklioğlu, G. Baskol, F. Bayram, Y. Ozkul, F. Elmalı, İ. Cakir, M. Mert, N. E. Gunay
®Copyright 2019 by Turkish Journal of Endocrinology and Metabolism Association Turkish Journal of Endocrinology and Metabolism published by Türkiye Klinikleri Evaluation of Paraoxonase1 Polymorphisms in Hypothyroid Patients and Their Relationship with Paraoxonase Activity and Serum Lipids Hipotiroidili Hastalarda Paraoksonaz1 Polimorfizmlerinin Değerlendirilmesi ve Bu Polimorfizmlerin Paraoksonaz Aktivitesi ve Serum Lipidleri ile İlişkisi
{"title":"Evaluation of Paraoxonase1 Polymorphisms in Hypothyroid Patients and Their Relationship with Paraoxonase Activity and Serum Lipids","authors":"Ayşen Caniklioğlu, G. Baskol, F. Bayram, Y. Ozkul, F. Elmalı, İ. Cakir, M. Mert, N. E. Gunay","doi":"10.25179/tjem.2019-66617","DOIUrl":"https://doi.org/10.25179/tjem.2019-66617","url":null,"abstract":"®Copyright 2019 by Turkish Journal of Endocrinology and Metabolism Association Turkish Journal of Endocrinology and Metabolism published by Türkiye Klinikleri Evaluation of Paraoxonase1 Polymorphisms in Hypothyroid Patients and Their Relationship with Paraoxonase Activity and Serum Lipids Hipotiroidili Hastalarda Paraoksonaz1 Polimorfizmlerinin Değerlendirilmesi ve Bu Polimorfizmlerin Paraoksonaz Aktivitesi ve Serum Lipidleri ile İlişkisi","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116446030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2019-65855
M. A. Eren, Ataman Gönel, I. Koyuncu, Ahmet Cebeli Gökay, T. Sabuncu
{"title":"Evaluation of the Frequency of Familial Hypercholesterolemia: A Single-Center Experience","authors":"M. A. Eren, Ataman Gönel, I. Koyuncu, Ahmet Cebeli Gökay, T. Sabuncu","doi":"10.25179/tjem.2019-65855","DOIUrl":"https://doi.org/10.25179/tjem.2019-65855","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128532841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：